As of Jul 22
| -0.09 / -4.37%|
The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +306.09% increase from the last price of 1.97.
The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.